Download: PDF RTF XML Booklet: Review (0) Retrieve Add item
ALzheimer COoperative Valuation in Europe [ALCOVE] [20102201] - Joint Actions
General objectives

The JA will be contribute to public health programmes in Europe and develop Alzheimers disease (AD) and dementia prevention and care models in different European countries. The aim is to contribute to improvements in health by supporting and facilitating quality and efficiency of public health and healthcare policies and interventions. Synergy and avoidance of duplication with other health and research programs will be ensured.
The aim is to build a sustainable European platform. The objectives of ALCOVE are to accomplish the following during the 2 year project duration:
1. Establish a European statement on Alzheimer`s disease: Propose a synthesis regarding AD information and practices in Europe which could be the basis for further implementation at the European level
2. Ability of the JA to support the implementation of good practices in the field of risk prevention with measured results for patients: a focus on the overuse of psychotropics.

Strategic relevance and contribution to the public health programme

ALCOVE is a response to an explicit request by the EU and MS and covers a number of EU MS, incl. CZ, BE, GR, FI, IT, LV, LT, SK, ES, SE, UK and FR, pooling different competences across Europe with diverse experiences for the prevention and care of AD and dementia. Strategic relevance is enhanced by the involvement of various types organisations to provide scientific excellence and develop links for future collaborations between institutions involved in AD and dementia in EU countries. Due to the nature of AD and its impact on ageing and the aged as well as to national health systems (in terms of both social and economic impact) the ALCOVE JA corresponds to the approach outlined in the white paper: Together for Health: A Strategic Approach for the EU 2008-2013. The diagnosis and treatment of AD developpe several of the identified priority areas for 2010, including: Sustainability of health systems in the face of challenges such as the ageing population; Inequalities in health within and between MS; and Health security, surveillance and response to health threats.

Methods and means

The JA will build on methods and tools developed by international EuroCode and Dementia in Europe Yearbook (Alzheimer Europe) and relevant collaborations. It will comprise four fields and share a common question on risk reduction in population with AD, i.e. the overuse of psychotropics. WPs are devoted to: 1 Improvement of knowledge, using existing epidemiological collection data and connecting of these studies with other national info systems. 2 Improvement of risk prevention and diagnosis, based on better knowledge of effectiveness of preventive strategies, using an assessment of implementation of these strategies. Improvement of diagnosis: improvement of operational criteria of diagnosis and assessment of health care systems in order to formulate recommendations. 3 Improvement of existing practices and care models, based on assessment of info about care practices, training practices and evaluation of the rights of the persons with dementia (concerning professional and family carers). 4 Autonomy and dignity of people with dementia from an ethical and legal perspective (incl. ADW, competence assessment w/ overview of good practices.

Expected outcomes period

ALCOVE will support effective collaboration for improving the AD public health problem in Europe that brings added value at the European, national and regional levels. The JA aims to bring better knowledge and development of risk prevention and care recommendations to facilitate policy and health care decision making in EU MS. The main outcome will be the establishment of a network for risk prevention and care of dementia in EU, with the hope that EU MS not yet involved in this JA will, in the future, join the network. Exchange of information among agencies will be increased, avoiding duplication of work in the field of AD and other dementia in EU. Availability of information allows MS to adapt recommendations to each situation, allowing better efficacy. Finally, emerging and future developments in the domains of risk prevention and care improvement, will be more easily disseminated and implemented.

Start date: 01/04/2011
End date: 01/04/2013
Duration: 24 month(s)
Current status: Finalised
Programme title: Second Programme of Community action in the Field of Health 2008-2013
EC Contribution: € 613 100,00